Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock

1. We investigated the effects of recombinant human erythropoietin (rh-EPO) in splanchnic artery occlusion (SAO) shock. Sham operated animals were used as controls. Survival rate, mean arterial blood pressure (MAP), serum Tumor Necrosis Factor (TNF-α), plasma nitrite/nitrate concentrations, red bloo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Squadrito, Francesco, Altavilla, Domenica, Squadrito, Giovanni, Campo, Giuseppe M, Arlotta, Mariarita, Quartarone, Cristina, Saitta, Antonino, Caputi, Achille P
Formato: Artigo
Lenguaje:Inglês
Publicado: 1999
Materias:
Papers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1566014/
https://ncbi.nlm.nih.gov/pubmed/10385249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0702521
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares